A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects
Status:
Completed
Trial end date:
2020-11-16
Target enrollment:
Participant gender:
Summary
The 2 × 2 crossover designed study is to evaluate the bioequivalence of two different
amphotericin B liposome for injection after single IV infusion at the same dose in normal
healthy subjects.